Izeradjene et al. described XIAP downregulation in colorectal cancer cells following the administration of the CK1 inhibitor CKI-7 only if combined with TRAIL (37) and in CK2α knocked-down rhabdomyosarcoma cells (36). The gene discussed is XIAP; the disease is rhabdomyosarcoma.